However, published reports have been partly controversial and concerning maternal serum glycosylated fibronectin, that was reported to have excellent performance, there are only few published reports suggesting its usefulness as first trimester predictor of subsequent GDM [6, 13]. The gene discussed is FN1; the disease is gestational diabetes.